Jove
Visualize
Contact Us

Related Experiment Videos

Multiple sclerosis: an immunologic perspective.

Jimmy Y Cui1

  • 1Department of Rehabilitation Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA. jcui66@hotmail.com

Physical Medicine and Rehabilitation Clinics of North America
|May 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Preface.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Unbound: A Comprehensive Review.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Dual Frontiers Cancer and Palliative Care.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Management Across Special Populations: Pediatrics, Geriatrics, and Pregnancy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Healing from Within: Regenerative Medicine in Pain Therapy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

The Brain in Pain: Exploring Central Pain Disorders.

Physical medicine and rehabilitation clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

The exact cause of multiple sclerosis (MS) is unknown, but immune cells and their inflammatory responses are key to lesion formation and disease progression. Understanding these mechanisms guides current MS treatment strategies.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Background:

  • The precise etiology of multiple sclerosis (MS) remains elusive.
  • Immunopathologic studies implicate activated immune cells in MS lesion development.
  • Both cell-mediated and antibody-mediated (humoral) immune responses contribute to MS pathogenesis.

Purpose of the Study:

  • To explore the role of immune responses in multiple sclerosis (MS) pathogenesis.
  • To review the mechanisms of action for common immunotherapy agents used in MS treatment.
  • To analyze the impact of these therapies on the immune system of MS patients.

Main Methods:

  • Review of immunopathologic studies on MS.
  • Analysis of cytokine profiles related to T helper 1 (Th1) and T helper 2 (Th2) cells.

Related Experiment Videos

  • Examination of the mechanisms of action of established MS immunotherapies.

    • Main Results:

    • Activated immune cells are integral to the formation of MS lesions.
    • T helper 1 (Th1) and T helper 2 (Th2) cells, via cytokine release, modulate immune balance and inflammation.
    • Current understanding of MS immunopathogenesis informs therapeutic strategies.

    Conclusions:

    • The immunopathogenesis of MS involves complex interactions between different immune cell types and cytokines.
    • Therapeutic strategies for MS are increasingly focused on modulating these immune responses.
    • Further research into immune mechanisms is crucial for developing more effective MS treatments.